Search

everythinglearnresearchcommunity

for

Search:↓

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

SHISA6 helps maintain certain stem cells in mouse testes by blocking signals that would otherwise cause them to differentiate.

Introducing the rat OTC gene normalized hair growth in SPF-ASH mice.

New genetic variants linked to inherited ichthyoses were identified, offering insights for potential gene therapy.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

CRPS type I is a complex pain condition with no proven cure, requiring personalized treatment.

TLR3 activation helps improve skin and hair follicle healing in mice.

TRM21 helps control flavonoid production and root hair growth in Arabidopsis thaliana.

TCF/Lef1 is essential for skin barrier function by regulating lipid metabolism.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Alopecia areata patients have higher systemic inflammation, even in mild cases.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Four-amino acid part makes enzyme sensitive to finasteride.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Sinapic acid may protect skin cells from UV damage and reduce inflammation, making it a promising anti-aging cosmetic ingredient.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Mcl-1 can activate Wnt signaling in skin cells, promoting growth and possibly cancer.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

Acute stress increases Y1 receptor gene expression in certain brain areas, but repeated stress does not.